Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmadrug Inc C.PHRX

Alternate Symbol(s):  LMLLF

PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases and rare cancers. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also operates through SecureDose Synthetics Inc., which is a pharmaceutical research and development company focused on the development of synthetic formulations of existing drugs for potential commercialization and distribution.


CSE:PHRX - Post by User

Post by JefffCEOon Mar 24, 2021 7:13pm
93 Views
Post# 32872234

USD $70 Million needed for Stage III FDA approval for orphan

USD $70 Million needed for Stage III FDA approval for orphanIt is $200 Million plus for Stage III approval.  Orphan approval will cost USD $70 Million.

Call the General Counsel's office at the US FDA.  

Just trying to guess how they will write a cheque for US $ 70 Million

That is one billion shares at 7 cents US or 9 cents CDN.

Let me know how they will complete that financing.  

My stock is still $1.50

Yours is barely holding on to a dime

1.1 Billion shares of BUZZ traded since 5 months ago and its up 6 cents per share ....mmmmm

Captains of Industry Goldy63 and FemDom678
<< Previous
Bullboard Posts
Next >>